Cart
sales@molnova.com
Diquafosol tetrasodium
CAS No. 211427-08-6
Diquafosol tetrasodium( INS365 )
Catalog No. M20787 CAS No. 211427-08-6
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 173 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 446 | In Stock |
|
| 500MG | 972 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiquafosol tetrasodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
-
DescriptionDiquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
-
In Vitro——
-
In Vivo——
-
SynonymsINS365
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorP2Y2 receptor
-
Research Area——
-
IndicationDiquafosol tetrasodium
Chemical Information
-
CAS Number211427-08-6
-
Formula Weight878.23
-
Molecular FormulaC18H22N4Na4O23P4
-
Purity>98% (HPLC)
-
SolubilityH2O:100 mg/mL (113.87 mM; Need ultrasonic);DMSO:1 mg/mL (1.14 mM; Need ultrasonic)
-
SMILESO=c1ccn(C2OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3OC(n4ccc(=O)[nH]c4=O)C(O)C3O)C(O)C2O)c(=O)[nH]1.[Na+].[Na+].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee J H Lee J S Kim S et al. Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on Human corneal epithelial cells[J]. Korean Journal of Physiology and Pharmacology 2017 21(2):189.
molnova catalog
related products
-
BX430
BX430 is used for chronic pain and cardiovascular disease and it is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity.
-
BzATP triethylammoni...
BzATP triethylammonium salt is a P2X7 receptor agonist.
-
PSB-12062
PSB-12062 is a potent and selective antagonist of P2X4(IC50 of 1.38 μM for human P2X4). PSB-12062 is ?a selective P2X4 antagonist that was equally potent in all three species (IC(50): 0.928-1.76 μM).?The compounds showed an allosteric mechanism of action.?
